Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis

This publication has 12 references indexed in Scilit:

• A Prospective Study of High-Grade Cervical Neoplasia Risk Among Human Papillomavirus-Infected Women
  JNCI Journal of the National Cancer Institute, 2002
• Persistent human papillomavirus infection and cervical neoplasia
  The Lancet Oncology, 2002
• Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
  International Journal of Cancer, 2001
• Differential Frequencies of p16^INK4a Promoter Hypermethylation, p53 Mutation, and K-ras Mutation in Exfoliative Material Mark the Development of Lung Cancer in Symptomatic Chronic Smokers
  Journal of Clinical Oncology, 2000
• In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis
  Proceedings of the National Academy of Sciences, 1999
• Expression Status of p16 Protein Is Associated with Human Papillomavirus Oncogenic Potential in Cervical and Genital Lesions
  The American Journal of Pathology, 1998
• Expression of cellular genes in HPV16-immortalized and cigarette smoke condensate-transformed human endocervical cells
  Journal of Cellular Biochemistry, 1997
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
  Proceedings of the National Academy of Sciences, 1996
• The retinoblastoma protein and cell cycle control
  Cell, 1995
• G1 phase progression: Cycling on cue
  Cell, 1994